Springer Timothy A

Springer Timothy A is listed in filings as Director, 10% Owner at Cartesian Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including purchase activity. Recent filings connect the profile to Cartesian Therapeutics, Inc. (RNAC) and Tectonic Therapeutic, Inc. (TECX). The current snapshot covers public activity from Jun 24, 2024 to Jan 6, 2026. Reported amounts are shown as $52.7K to $875.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.